levodopa and quinone
levodopa has been researched along with quinone in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Arthur, RE; Kuhn, DM | 1 |
| Asanuma, M; Emdadul Haque, M; Higashi, Y; Miyazaki, I; Ogawa, N; Tanaka, K | 1 |
| Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Ogawa, N; Shimizu, M; Tanaka, K | 1 |
Other Studies
4 other study(ies) available for levodopa and quinone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein.
Topics: Antioxidants; Benzoquinones; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Levodopa; Monophenol Monooxygenase; Nitroblue Tetrazolium; Oxidation-Reduction; Reducing Agents; Staining and Labeling; Sulfhydryl Compounds; Tryptophan Hydroxylase | 1999 |
Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells.
Topics: Apoptosis; Benzoquinones; Caspase 3; Caspases; Catalase; Catechols; Dopamine; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Superoxide Dismutase; Tumor Cells, Cultured | 2003 |
Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antiparkinson Agents; Benzoquinones; Benzothiazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electron Spin Resonance Spectroscopy; Functional Laterality; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease; Pramipexole; Thiazoles; Time Factors | 2005 |